Aurobindo Pharma Ltd. plans to acquire a portfolio of seven branded oncology injectable products from Spectrum Pharmaceuticals Inc. The acquisition involves an upfront payment of USD 160 million in cash,…Read More
The audit of the Dr Reddy’s Laboratories’ formulations Srikakulum Plant (SEZ) Unit I, Andhra Pradesh by the US Food and Drug Administration (USFDA), has been completed. The company has received…Read More
Cadila Pharmaceuticals Ltd. has signed an agreement with Norway-based Inven2’s start-up, SERCA Pharmaceuticals, to develop a new treatment for heart patients. The new drug is based on an invention by…Read More
Glenmark Pharmaceuticals is targeting a consolidated revenue growth of up to 15 percent over the next 3 to 5 years. This would be mainly on account of strengthening the current…Read More
Pfizer Inc. has decided to shut down its manufacturing units in Irungattukottai, Chennai, and Aurangabad, Maharashtra, which came to it through an acquisition of injectables manufacturer Hospira in 2015. While…Read More
Sun Pharma has entered into a definitive agreement to acquire Pola Pharma, which is engaged in research and development, manufacture, sale, and distribution of branded, and generic products in Japan….Read More
Lupin is in the process of developing a pipeline of products under its new drug discovery program to treat various diseases like cancer and metabolic disorders. The company, which last…Read More
Suven Life Sciences has received one product patent from Brazil and one from Eurasia corresponding to the new chemical entities for the treatment of disorders associated with neurodegenerative diseases. These…Read More
Glenmark Pharmaceuticals Limited announced its financial results for the second quarter (2Q) ended September 30 of financial year 2018-19. In the 2Q, Glenmark’s consolidated revenue was at Rs 25,813.32 million as…Read More
Sun Pharmaceutical has entered into a definitive agreement to acquire Pola Pharma Inc., a Japanese pharmaceutical company engaged in research and development, manufacture, sale, and distribution of branded and generic…Read More
Piramal Pharma Solutions has completed its new cGMP kilo lab suite at its API (active pharmaceutical ingredient) site in Ennore (Chennai). Ennore is a key API site in the PPS…Read More
Strides Pharma Science’s board has approved participation in the Series B fundraiser of Stelis Biopharma with a commitment of USD 15 million. The first close of the current fund raise…Read More
In a bid to strengthen its presence in therapy areas such as dermatology and anti-infectives, pharmaceutical major Lupin is eyeing product acquisitions in the same. The fifth-largest Indian pharma company…Read More
Dr Reddy’s Laboratories has informed exchanges that the audit of its formulations Srikakulum Plant (SEZ) Unit II, Andhra Pradesh, by the US Food Drug Administration has been complete and after…Read More
Sun Pharma plans to invest an additional Rs 200 crore at its plant in the state of Assam to augment operations. Assam Chief Minister Sarbananda Sonowal inaugurated a new production line…Read More